The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.
A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.
Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.
This autumn the chancellor Rishi Sunak will set out the Government’s spending priorities. Here’s why it’s time to invest in cancer services and research.
Campaigner Patrick McGuire writes to Boris Johnson about honouring his manifesto commitments in the upcoming Comprehensive Spending Review.
We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%.
At least 14,000 fewer people have been urgently referred for lung cancer tests since March.
The National Institute for Health and Care Excellence has approved the drug osimertinib to treat some adults in England with untreated, advanced lung cancer.
Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.